IMU 0.00% 10.5¢ imugene limited

Clinical stage immuno-oncology company Imugene Limited (ASX:IMU)...

  1. Clinical stage immuno-oncology company Imugene Limited (ASX:IMU) has been granted a trading halt by the ASX, with its shares placed in pre-open.

    Imugene is currently preparing to release capital raising details.

    The company is developing HER-2+ gastric and breast cancer immunotherapies.

    The halt will remain in place until the opening of trade on Wednesday 9th September 2015, or earlier if an announcement is made to the market.

     

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $768.4M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $746.7K 7.120M

Buyers (Bids)

No. Vol. Price($)
176 10004604 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 420568 8
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
10.3¢
  Change
0.000 ( 2.40 %)
Open High Low Volume
10.3¢ 10.5¢ 10.3¢ 1930285
Last updated 15.59pm 28/03/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.